EMERGENT BIOSOLUTIONS INC. — Cash Flow Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-201.8% -$23M
$-34M
Free Cash Flow↓-144.6% -$21M
$-36M
Investing Cash Flow↓-104.0% -$62M
$-2M
Financing Cash Flow↓-2750.0% -$11M
$-11M
Capex↓-33.3% -$1M
$2M
Acquisitions
—
Stock Buybacks
$9M
Stock-Based Comp↑+26.7% +$400K
$2M
Debt Issued
—
Debt Repaid
—
D&A↓-7.5% -$2M
$24M
SBC Allocated Expense↑+26.7% +$400K
$2M